Do We Still Need Pioglitazone for The Management of Type 2 Diabetes Mellitus? A Peep In To Risk of Bladder Cancer in Diabetic Population

Journal Title: Journal of Endocrinology and Diabetes - Year 2018, Vol 5, Issue 2

Abstract

Pioglitazone use and risk of bladder cancer in diabetic patient one of the major cause of morbidity and mortality. Increasing evidence from the clinical studies suggested increased risk of bladder cancer with higher dose and longer duration of pioglitazone use. In contrast, few studies reported non-significant association with pioglitazone use and risk of bladder cancer in T2DM patients. Therefore, we aimed to review and summarize the available clinical data describing the risk of bladder cancer associated with pioglitazone treatment.

Authors and Affiliations

Manju Sharma, Azharuddin n, Tarique Faheem, Mohammad Adil, Pinaki Ghosh

Keywords

Related Articles

Exercise Capacity of Patients with Type 2 Diabetes: a Mini Review of Clinical Findings

In this mini review, we aimed to clarify the contributors to impaired cardiorespiratory fitness in patients with type 2 diabetes and to discuss how to improve cardiorespiratory fitness in this population. Patients with t...

Social Representations of Feeding People with Type-2 Diabetes Mellitus

The aim of this study was to analyze the social representations of the diets 34 patients of the Brazilian public primary care service diagnosed with type- 2 diabetes mellitus, according to how they represent their identi...

Outcome of Patients with Diabetic Ketoacidosis in South of Iran

Introduction: Diabetic Keto acidosis (DKA) is the most common cause of mortality in children with diabetes mellitus. The aim of this study is to investigate the complications of DKA and its complications in hospitalized...

Parathyroid Gland FNA and PTH Washout; Diagnostic Value in Patients with Primary Hyperparathyroidism

Primary hyperparathyroidism is the most common cause of hypercalcemia in outpatients and it is usually attributed to parathyroid adenoma, which is managed by surgical resection of the adenoma. Successful management requi...

Highly Purified Eicosapentaenoic Acid Improves Decreased Toe-Brachial Index in Japanese Patients with Type 2 Diabetes Mellitus

Eicosapentaenoic acid (EPA), which is an important polyunsaturated fatty acid in fish oil, improves blood coagulability and prevents thrombosis. EPA is usually available for treatment of patients with obliterating arteri...

Download PDF file
  • EP ID EP334120
  • DOI 10.15226/2374-6890/5/2/01101
  • Views 105
  • Downloads 0

How To Cite

Manju Sharma, Azharuddin n, Tarique Faheem, Mohammad Adil, Pinaki Ghosh (2018). Do We Still Need Pioglitazone for The Management of Type 2 Diabetes Mellitus? A Peep In To Risk of Bladder Cancer in Diabetic Population. Journal of Endocrinology and Diabetes, 5(2), 1-2. https://www.europub.co.uk/articles/-A-334120